Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on ACELYRIN, INC. (SLRN – Research Report) today and set a price target of $20.00.

Acelyrin (SLRN) announced that its Phase 2b/3 trial of izokibep in non-infectious, non-anterior uveitis did not meet the primary endpoint of a ...

10, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology ...

Acelyrin's lead drug izokibep showed mixed results in trials, leading to workforce cuts and a shift in focus to lonigutamab for thyroid eye disease. Despite positive PsA and HS data, market ...

MILAN, Dec. 5, 2024 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical company headquartered in Italy, presents positive results from Phase II MIRAKLE study, a multicentre, randomized, ...

Please view our affiliate disclosure. Creating a strong brand identity is one of the most important aspects of a business. A well-designed logo is often the first impression a company makes on ...

Mars has responded to comparisons between the new men’s Six Nations branding and its famous chocolate bar’s logo by describing the two brands as a “match made in heaven”. Supporters ...

A new logo for the men's Six Nations which aims to encapsulate the "electrifying action" of the tournament has attracted derision from many fans. Organisers unveiled the rebranding of the ...

The rebrand for 2025 coincides with the 25th anniversary of the inclusion of Italy in 2000 to create the first Six Nations A new logo for the men's Six Nations which aims to encapsulate the ...